Table 4.

Procedural data of Evolut-R, Portico and Lotus patients.

Variables	Evolut-R	Portico	Lotus	p-value
N	124 (53.4%)	78 (33.6%)	30 (12.9%)
Femoral route	113 (91.1%)	69 (88.5%)	30 (100%)	0.159
Subclavian route	11 (8.9%)	9 (11.5%)	0 (0.0%)	0.159
Embolic protection system	8 (6.5%)	2 (2.6%)	3 (10.0%)	0.269
Any vascular complications	8 (6.5%)	6 (7.7%)	1 (3.3%)	0.711
PTA with stenting of access site	1 (0.8%)	2 (2.6%)	1 (3.3%)	0.497
PCI with stenting	6 (4.8%)	6 (7.7%)	0 (0.0%)	0.263
Degree of oversizing (%)	20.8 $\pm$ 6.8	13.8 $\pm$ 6.8	1.1 $\pm$ 7.7	0.001
Predilatation	52 (41.9%)	60 (76.9%)	19 (63.3%)	0.001
Implantation depth NCC (mm)	4.3 $\pm$ 2.5	4.9 $\pm$ 2.7	3.4 $\pm$ 2.6	0.047
Implantation depth LCC (mm)	5.6 $\pm$ 3.0	6.8 $\pm$ 2.9	5.0 $\pm$ 3.1	0.012
Implantation depth mean (mm)	5.0 $\pm$ 2.6	5.8 $\pm$ 2.7	5.1 $\pm$ 2.6	0.015
Postdilatation	72 (58.1%)	48 (61.5%)	2 (6.7%)	0.001
Repositioning	15 (12.1%)	26 (3.3%)	14 (46.7%)	0.001
Recapture	27 (21.8%)	12 (15.4%)	8 (26.7%)	0.352
Emergent cardiac surgery	1 (0.08%)	0 (0.0%)	0 (0.0%)	0.646
Need for second valve	0 (0.0%)	1 (1.3%)	0 (0.0%)	0.371
Contrast volume (mL)	151.9 $\pm$ 63.0	167.2 $\pm$ 67.6	137.9 $\pm$ 37.3	0.132
Radiation dose (${\mathrm{Gycm}}^2$)	76.1 $\pm$ 51.5	81.0 $\pm$ 62.2	106.8 $\pm$ 55.2	0.182

LCC, left coronary cusp; NCC, non-coronary cusp; PCI, percutaneous coronary intervention; PTA, percutaneous transluminal angioplasty.